Warren Kruger Receives NIH Grant to Further Study Treatment of Rare Genetic Disorder Classical Homocystinuria
PHILADELPHIA (November 28, 2018) – Warren D. Kruger, PhD, has received a grant from the National Institutes of Health to study whether proteasome inhibitors (Pls) and proteostasis modulators are effective in restoring function to treating cystathionine beta synthase (CBS) deficiency, also known as classical homocystinuria.